FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38011000001105: Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17110901000001114 Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65915501000001119 Cystrin 3mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely oxybutynin hydrochloride 3 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Oxybutynin false Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Is a Cystrin true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) 56 tablet Is pack of False Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) 56 tablet Has AMP True Cystrin 3mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start